Ignite Creation Date:
2024-05-05 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 9:54 AM
Study NCT ID:
NCT00743444
Status:
COMPLETED
Last Update Posted:
2013-07-22
First Post:
2008-08-26
Brief Title:
TLESR-impedance Study in Patients
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Double-blind Placebo Controlled Randomized Two Centre Phase IIA Pharmacodynamic Cross-over Study to Assess the Effect of AZD3355 65 mg Bid on Transient Lower Esophageal Sphincter Relaxations TLESRs in GERD Patients With an Incomplete Response to PPI Treatment
Status:
COMPLETED
Status Verified Date:
2013-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to compare frequency and content of reflux episodes in patients with gastroesophageal reflux disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None